Literature DB >> 2497976

A pilot study of stiripentol, a new anticonvulsant drug, in complex partial seizures uncontrolled by carbamazepine.

O Rascol1, A Squalli, J L Montastruc, A Garat, G Houin, S Lachau, J Tor, H Blehaut, A Rascol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2497976     DOI： 10.1097/00002826-198904000-00006

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  6 in total

Review 1.  Stiripentol add-on therapy for drug-resistant focal epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Nicola Luigi Bragazzi
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

Review 2.  Stiripentol in the Management of Epilepsy.

Authors:  Katherine C Nickels; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

Review 3.  Newer antiepileptic drugs. Towards an improved risk-benefit ratio.

Authors:  P N Patsalos; J W Sander
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

Review 4.  New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.

Authors:  M Bebin; T P Bleck
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

Review 5.  Stiripentol add-on therapy for focal refractory epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Nicola Luigi Bragazzi
Journal:  Cochrane Database Syst Rev       Date:  2018-05-10

6.  Stiripentol add-on therapy for drug-resistant focal epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Nicola Luigi Bragazzi
Journal:  Cochrane Database Syst Rev       Date:  2020-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.